PULLMAN, Wash. – People suffering from post‑traumatic distress disorder report that cannabis reduces the severity of their symptoms by more than half, at least in the short term, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology. Read more here.
As health experts urge people to maintain social distancing, it remains to be seen how effectively Canadians can best practice this in the workplace. To learn more, continue reading HERE.
NEW HOPE, Pa.–VerdePharmHealth, the nation’s premier provider of comprehensive cannabis solutions – group purchasing organization, clinical solutions, and healthcare technology, today announced that Strainprint, a market leader in cannabis data and analytics, will partner to provide technology that supports the transformation of physician practices towards improved decision-support for medical cannabis interventions, coupled with patient-reported outcomes […]
A survey conducted on Valentine’s Day revealed that—surprise—users of the popular Strainprint app like to use cannabis to enhance their sex lives. A total of 1,400 responses to the survey were logged, with 75 percent of respondents saying they use cannabis in the bedroom. Most (53 percent) said they do so to achieve better orgasm, while almost half (43.8 […]
Almost 90 Percent of People Say Sex, Like Many Things, Is Better With Cannabis A whopping 87.1 percent of respondents agreed doing the nasty is taken to new heights when a little weed is added to the mix. By Emma Spears March 2, 2020 Like many things in life, sex is better with cannabis, at […]
74% of Cannabis Users Report Getting Lifted Before Getting Busy: Survey It’s high time to hop into bed with someone you fancy. And if you’re a cannabis user, there’s a good chance you’ll be hitting the skins after taking a hit, at least according to the findings of a new survey. On Valentine’s Day, users […]
Companies plan to establish Joint Venture that combines Strainprint’s comprehensive patient data with the StrainSecure™ traceability platform. Click HERE to learn more.
One of the biggest issues within Cannabis research today is the lack of sufficient data. This is why we’ve partnered with Gynica to launch the next stage of the much-anticipated clinical trial to develop a product formulation to treat endometriosis and its symptoms. If you suffer from endometriosis, please fill out this survey. This data […]
Canadian cannabis analytics company Strainprint Technologies launches groundbreaking medical cannabis patient retrospective report. The report summarizes key takeaways and results based on over 805,000 patient outcomes. Who Benefits from the Report? Read more at the source….